Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Brian Gazzard

Datos Biográficos

ID9109269
NOMBREBrian Gazzard
NOMBRESBrian
APELLIDOGazzard
FIRMAGAZZARD B
AFILIACIONESChelsea and Westminster Hospital
VERIFICADONo
TOTAL DE OBRAS12
TOTAL DE CITAS0
TOTAL COMO AUTOR12
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN1992
AÑO MÁS RECIENTE DE PUBLICACIÓN2016
ÍNDICE H0
  • Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD)

    Open Access•Sheena McCormack, D Dunn et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection. However, this benefit could be counteracted by risk compensation in users of PrEP. We did the PROUD study to assess this effect. METHODS: PROUD is an open-label randomised trial done at 13 sexual health clinics in England. We enrolled HIV-negative gay and other men who have sex…

  • Screening for HIV-related neurocognitive impairment in clinical practice

    T J Barber, TJ Barber et al.•ARTICLE•AIDS Care•2014

    With increasingly successful management of HIV, focus has shifted away from AIDS-related complications to other chronic co-morbidities. For HIV-related cognitive problems, the true aetiopathogenesis and epidemiology remains unclear. Rather than a systematic review, this paper presents the challenges and the opportunities we faced in establishing our own clinical service. Papers were identified using Pubmed and the terms "screening", "HIV" and "ne…

  • HIV-related neurocognitive impairment screening

    Alastair Nightingale, Denise Ratcliffe et al.•ARTICLE•AIDS Care•2014

    Despite ever improving advances in antiretroviral therapy, neurocognitive impairments such as asymptomatic and mild neurocognitive impairment remain a significant problem for the HIV-positive population. We distributed a post-neurocognitive impairment screening service evaluation questionnaire to assess satisfaction and anxiety. Subjects were HIV positive and aged 18-50. They were screened using the Brief Neurocognitive Score and International HI…

  • Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome

    John Walsh, John C Walsh et al.•ARTICLE•AIDS•2002

    OBJECTIVES: Many questionnaires on adherence to antiretroviral therapy are in use, but the validity of patients' responses has not been tested. The Medication Adherence Self-Report Inventory (MASRI) has been developed and tested for its validity against objective measures and treatment outcome. DESIGN: Prospective study comparing questionnaire responses with MEMS TrackCap (MC, a medication event monitoring system), pill count (PC) and plasma HIV …

  • Reasons for non-adherence to antiretroviral therapy

    John Walsh, J C Walsh et al.•ARTICLE•AIDS Care•2001

    The objective of the study was to define common reasons for non-adherence (NA) to highly active antiretroviral therapy (HAART) and the number of reasons reported by non-adherent individuals. A confidential questionnaire was administered to HIV-seropositive patients taking proteinase inhibitor based HAART. Median self-reported adherence was 95% (n = 178, range = 60-100%). The most frequent reasons for at least 'sometimes' missing a dose were eatin…

  • Reasons given by patients for 'non-progression' in HIV infection

    Maxine Troop, Philippa Easterbrook et al.•ARTICLE•AIDS Care•1997

    Identification of the reasons for long-term survival in HIV infection is an area of current intense research. The objective of this study was to determine the perceptions among patients with different rates of disease progression as to the reasons for a good outcome with HIV. In a case-control study of 134 long-term (> or = 8 years) HIV-infected participants, 62 were defined as non-progressors; current CD4 cell count > or = 500 x 10(6)/L and asym…

  • Are people with HIV in London able to die where they plan

    Bruce Guthrie, M Nelson et al.•ARTICLE•AIDS Care•1996

    Being able to die where you plan is a measure of quality of life near death, in that it implies awareness of diagnosis and prognosis, adequate symptom control and involvement in decision-making in late-stage HIV disease. This study presents trends in place of death for patients attending a large central London HIV centre and examines whether patients dying over a 6-month period in 1994 were able to die where they planned. Early in the epidemic al…

  • Testing patients for HIV before surgery

    Kate Chapman, J Meadows et al.•ARTICLE•AIDS Care•1995

    The aim of this study was to investigate the attitudes of doctors performing surgery to the HIV antibody testing of surgical patients. Fifty of eighty (62.5%) doctors performing surgery who are working in two London teaching hospitals returned completed anonymous postal questionnaires. Sixty-six per cent of the sample would like some form of compulsory testing of pre-operative patients, although most of them feel that this is only necessary for p…

  • Whose health is it? Views about decision-making and information-seeking from people with HIV infection and their professional carers

    Jose Catalan, Nancy D Brener et al.•ARTICLE•AIDS Care•1994

    The views of people with HIV and their professional carers about patients' views on involvement in decision-making and information-seeking were studied, using a standardized self-report instrument. Patients and staff reported high levels of desire for patients' involvement in their care, but there were important differences between groups. Staff had higher preference for patients' involvement in decision-making than the patients themselves, while…

  • How should a positive HIV result be given? The patients' view

    Andrea Pergami, Jose Catalan et al.•ARTICLE•AIDS Care•1994

    The study aimed at obtaining information about the experience of how the diagnosis of HIV infection was given. Thirty asymptomatic HIV seropositive subjects completed a self-report questionnaire enquiring about their views of the process of communication of a positive test result. Subjects' current mood was assessed with the Hospital Anxiety and Depression Scale (HAD). Only about one-third of subjects were definitely satisfied with the way they w…

  • “I plan to have the HIV test”—predictors of testing intention in women attending a London antenatal clinic

    J Meadows, Jose Catalan et al.•ARTICLE•AIDS Care•1993

    In order to identify which factors predict a parturient womans intention to take up voluntary HIV testing in the antenatal clinic, 318 women were surveyed by anonymous self-completion questionnaire. The strongest predictors of intention to be tested were the perceived benefit of the test to the woman herself, her partner, and the midwife, perceived risk of HIV infection, younger age and being single and having a poor knowledge of the sexual route…

  • Testing for HIV in the antenatal clinic

    J Meadows, Jose Catalan et al.•ARTICLE•AIDS Care•1992

    Self administered questionnaires were given to 34 midwives, who regularly counsel parturient women about the HIV antibody test, to investigate their attitudes to the test being offered in the antenatal clinic. Most of the midwives felt that testing should not be compulsory and that the test should be offered to all pregnant women who ask for it, not only those in recognized risk groups. Most also felt that women should be told the results of the …

Sin obras prominentes en esta página.

  • Testing for HIV in the antenatal clinic

    J Meadows, Jose Catalan et al.•ARTICLE•AIDS Care•1992

    Self administered questionnaires were given to 34 midwives, who regularly counsel parturient women about the HIV antibody test, to investigate their attitudes to the test being offered in the antenatal clinic. Most of the midwives felt that testing should not be compulsory and that the test should be offered to all pregnant women who ask for it, not only those in recognized risk groups. Most also felt that women should be told the results of the …

  • “I plan to have the HIV test”—predictors of testing intention in women attending a London antenatal clinic

    J Meadows, Jose Catalan et al.•ARTICLE•AIDS Care•1993

    In order to identify which factors predict a parturient womans intention to take up voluntary HIV testing in the antenatal clinic, 318 women were surveyed by anonymous self-completion questionnaire. The strongest predictors of intention to be tested were the perceived benefit of the test to the woman herself, her partner, and the midwife, perceived risk of HIV infection, younger age and being single and having a poor knowledge of the sexual route…

  • Whose health is it? Views about decision-making and information-seeking from people with HIV infection and their professional carers

    Jose Catalan, Nancy D Brener et al.•ARTICLE•AIDS Care•1994

    The views of people with HIV and their professional carers about patients' views on involvement in decision-making and information-seeking were studied, using a standardized self-report instrument. Patients and staff reported high levels of desire for patients' involvement in their care, but there were important differences between groups. Staff had higher preference for patients' involvement in decision-making than the patients themselves, while…

  • How should a positive HIV result be given? The patients' view

    Andrea Pergami, Jose Catalan et al.•ARTICLE•AIDS Care•1994

    The study aimed at obtaining information about the experience of how the diagnosis of HIV infection was given. Thirty asymptomatic HIV seropositive subjects completed a self-report questionnaire enquiring about their views of the process of communication of a positive test result. Subjects' current mood was assessed with the Hospital Anxiety and Depression Scale (HAD). Only about one-third of subjects were definitely satisfied with the way they w…

  • Testing patients for HIV before surgery

    Kate Chapman, J Meadows et al.•ARTICLE•AIDS Care•1995

    The aim of this study was to investigate the attitudes of doctors performing surgery to the HIV antibody testing of surgical patients. Fifty of eighty (62.5%) doctors performing surgery who are working in two London teaching hospitals returned completed anonymous postal questionnaires. Sixty-six per cent of the sample would like some form of compulsory testing of pre-operative patients, although most of them feel that this is only necessary for p…

  • Are people with HIV in London able to die where they plan

    Bruce Guthrie, M Nelson et al.•ARTICLE•AIDS Care•1996

    Being able to die where you plan is a measure of quality of life near death, in that it implies awareness of diagnosis and prognosis, adequate symptom control and involvement in decision-making in late-stage HIV disease. This study presents trends in place of death for patients attending a large central London HIV centre and examines whether patients dying over a 6-month period in 1994 were able to die where they planned. Early in the epidemic al…

  • Reasons given by patients for 'non-progression' in HIV infection

    Maxine Troop, Philippa Easterbrook et al.•ARTICLE•AIDS Care•1997

    Identification of the reasons for long-term survival in HIV infection is an area of current intense research. The objective of this study was to determine the perceptions among patients with different rates of disease progression as to the reasons for a good outcome with HIV. In a case-control study of 134 long-term (> or = 8 years) HIV-infected participants, 62 were defined as non-progressors; current CD4 cell count > or = 500 x 10(6)/L and asym…

  • Reasons for non-adherence to antiretroviral therapy

    John Walsh, J C Walsh et al.•ARTICLE•AIDS Care•2001

    The objective of the study was to define common reasons for non-adherence (NA) to highly active antiretroviral therapy (HAART) and the number of reasons reported by non-adherent individuals. A confidential questionnaire was administered to HIV-seropositive patients taking proteinase inhibitor based HAART. Median self-reported adherence was 95% (n = 178, range = 60-100%). The most frequent reasons for at least 'sometimes' missing a dose were eatin…

  • Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome

    John Walsh, John C Walsh et al.•ARTICLE•AIDS•2002

    OBJECTIVES: Many questionnaires on adherence to antiretroviral therapy are in use, but the validity of patients' responses has not been tested. The Medication Adherence Self-Report Inventory (MASRI) has been developed and tested for its validity against objective measures and treatment outcome. DESIGN: Prospective study comparing questionnaire responses with MEMS TrackCap (MC, a medication event monitoring system), pill count (PC) and plasma HIV …

  • Screening for HIV-related neurocognitive impairment in clinical practice

    T J Barber, TJ Barber et al.•ARTICLE•AIDS Care•2014

    With increasingly successful management of HIV, focus has shifted away from AIDS-related complications to other chronic co-morbidities. For HIV-related cognitive problems, the true aetiopathogenesis and epidemiology remains unclear. Rather than a systematic review, this paper presents the challenges and the opportunities we faced in establishing our own clinical service. Papers were identified using Pubmed and the terms "screening", "HIV" and "ne…

  • HIV-related neurocognitive impairment screening

    Alastair Nightingale, Denise Ratcliffe et al.•ARTICLE•AIDS Care•2014

    Despite ever improving advances in antiretroviral therapy, neurocognitive impairments such as asymptomatic and mild neurocognitive impairment remain a significant problem for the HIV-positive population. We distributed a post-neurocognitive impairment screening service evaluation questionnaire to assess satisfaction and anxiety. Subjects were HIV positive and aged 18-50. They were screened using the Brief Neurocognitive Score and International HI…

  • Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD)

    Open Access•Sheena McCormack, D Dunn et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection. However, this benefit could be counteracted by risk compensation in users of PrEP. We did the PROUD study to assess this effect. METHODS: PROUD is an open-label randomised trial done at 13 sexual health clinics in England. We enrolled HIV-negative gay and other men who have sex…

Medicine (12 obras) · HIV/AIDS Research and Interventions (10 obras) · Family medicine (9 obras) · Psychology (6 obras) · HIV Research and Treatment (4 obras) · Antiretroviral therapy (3 obras) · Disease (3 obras) · Environmental health (3 obras) · Internal Medicine (3 obras) · Population (3 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae